Federal Trade Commission accuses three drug middlemen of inflating insulin prices
In a lawsuit, the FTC accused Optum Rx, Caremark and Express Scripts of creating "a broken rebate system that inflated insulin drug prices, boosting PBM (prescription drug benefit managers) profits at the expense of vulnerable patients.
A Federal Trade Commission (FTC) report found that social and video streaming services pose serious privacy risks, especially ...
The investigation also highlights the companies' failure to adequately protect users, particularly children and teenagers.
The federal government is suing some big pharmacy benefit managers over a system of drug rebates that regulators say has made ...
Cigna Group’s Express Scripts sued the US Federal Trade Commission over a recent report that the company said demonizes ...
Last month, the Federal Trade Commission (FTC) and U.S. Department of Justice (DOJ) jointly hosted a public meeting of the interagency “Strike ...
California courts were home to the most federal trade secrets litigation over the past three years, according to a report ...
A new industry-backed plastics recycling bill in Congress supports chemical recycling and calls for a national 30 percent ...
Three companies that process about 80% of prescriptions in the United States — Caremark, Express Scripts and OptumRx — have ...
On Monday, fashion icon Michael Kors testified in an antitrust trial in Manhattan as a Federal Trade Commission lawsuit filed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback